Abstract
The level of an antibiotic capable of inhibiting the etiological agent at the site of infection is an essential prerequisite for successful antibiotic therapy. In some cases, locally applied antibiotics may compensate for limitations of systemic administration and shorten systemic therapy. We aimed at verifying to what extent vancomycin (Van) bound to ground bone grafts is usable in the treatment of serious infections. The levels of released Van significantly exceeded the Van minimum inhibitory concentration, which can suppress Van-sensitive staphylococci and Van intermediate Staphylococcus aureus, for the whole period of a 16-day measurement. Our results indicate that bone grafts can be used as Van carriers in therapy of osteomyelitis caused by Van-sensitive Staphylococcus strains.
Similar content being viewed by others
Abbreviations
- Van:
-
Vancomycin
References
Appelbaum PC (2007) Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 30:398–408
Bahrs C, Marschal M, Weise K, Lingenfelter E, Dietz K, Heeg P, Eingartner C (2006) Acute musculoskeletal infection: comparison of different methods for intraoperative bacterial identification. Acta Chir Orthop Traumatol Cech 73:237
Barcia-Macay M, Mouaden F, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F (2008) Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts). J Antimicrob Chemother 61:1288–1294
Bert F, Leflon-Guibout V, Le Grand J, Bourdon N, Nicolas Chanoine MH (2009) Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review. Pathol Biol (Paris) 57:56–60
Boucher H, Miller GL, Ranozabler R (2010) Serious infection caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 51:184–197
Buttaro M, González Della Valle AM, Pineiro L, Mocetti E, Morandi AA, Piccaluga F (2003) Incorporation of vancomycin-supplemented bone incorporation of vancomycin-supplemented bone allografts: radiographical, histopathological and immunohistochemical study in pigs. Acta Orthop Scand 74:505–513
Campoccia D, Montanaro L, Speziale P, Arciola CR (2010) Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials 31:6363–7637
Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK (2003) Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348:1342–1347
Cunha BA (2008) Vancomycin revisited: a reappraisal of clinical use. Crit Care Clin 24:393–420
Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE (1996) Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthp Relat Res 333:245–251
Faden D, Faden HS (2009) The high rate of adverse drug events in children receiving prolonged outpatient parenteral antibiotic therapy for osteomyelitis. Pediatr Infect Dis J 28:539–541
Fraimow HS (2009) Systemic antimicrobial therapy in osteomyelitis. Semin Plast Surg 23:90–99
Fridkin SK (2001) Vancomycin intermediate and resistant Staphylococcus aureus: what infectious disease specialists need to know. Clin Infect Dis 32:429–439
Gallo J, Sauer P, Dendis M, Loveckova Y, Kolar M, Zapletalova J, Janout V (2006) Molecular diagnostics for the detection of prosthetic joint infection. Acta Chir Orthop Traumatol Cech 73:85
Jahoda D, Nyc O, Pokorny D, Landor I, Sosna A (2006a) Antibiotics in the prevention of infectious complications associated with joint replacement surgeries. Acta Chir Orthop Traumatol Cech 73:108
Jahoda D, Nyc O, Pokorny D, Landor I, Sosna A (2006b) Linezolid in the treatment of resistant Gram-positive infections of the motor system. Acta Chir Orthop Traumatol Cech 73:329
Jahoda D, Nyc O, Simsa J, Kucera E, Hanek P, Chrz P, Pokorny D, Tawa N, Landor I, Sosna A (2007) The occurrence of late hematogenic infections of joint replacements in our set and a proposal for system prevention. Acta Chir Ortop Traumatol Cech 74:397
Jahoda D, Nyc O, Simsa J, Kucera E, Hanek P, Chrz P, Pokorny D, Tawa N, Landor I, Sosna A (2008a) Late hematogenic infections of joint replacements. Acta Chir Ortop Traumatol Cech 75:88–92
Jahoda D, Sosna A, Nyc O et al (2008b) Infectious complications of joint replacements. Triton, Prague
Jahoda D, Pokorny D, Nyc O, Bartak V, Hrohadka R, Landor I, Sosna A (2008c) Infectious complications of total shoulder arthroplasty. Acta Chir Ortop Traumatol Cech 75:422–428
Meani E, Romano C, Crosby L, Hofmann G (2008) Infection and local treatment in orthopedic surgery. Springer, New York
Melter O, Aires de Sousa M, Laskafeldova K, Urbaskova P, Wünschova M, de Lencastre H (2004) Delineation of the endemic and sporadic methicillin-resistant Staphylococcus aureus clones in a Czech hospital. Microb Drug Resist 10:218–223
Nyc O, Matejkova J (2010) Stenotrophomonas maltophilia: significant contemporary hospital pathogen—review. Folia Microbiol 55:286–294
Parvizi J, Azzam K, Ghanem E, Austin MS, Rothman RH (2009) Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Clin Orthop Relat Res 467:1732–1739
Randelli P, Evola FR, Cabitza P, Polli L, Denti M, Vaienti L (2009) Prophylactic use of antibiotic-loaded bone cement in primary total knee replacement. Knee Surg Sports Traumatol Arthrosc 18:181–186
Somerville AL, Wright DH, Rotschafer JC (1999) Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease. Pharmacother 19:702–707
von Eiff C, Peters G, Heilmann C (2002) Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2:677–685
Winkler H, Janata O, Berger C, Wein W, Georgopoulos A (2000) In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother 46:423–428
Winkler H, Stobier A, Kaudela K, Winter F, Menschik F (2008) One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg Br 90:1580–1584
Witso E, Persen L, Loseth K, Bergh K (1999) Adsorption and release of antibiotics from morselized cancellous bone. Acta Orthop Scand 70:298–304
Witso E, Persen L, Benum P, Bergh K (2005) Cortical allograft as a vehicle for antibiotic delivery. Acta Orthop Scand 76:481–486
Acknowledgments
The financial support by the project MZCR for conceptual development of research organization 00064203 is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Melicherčík, P., Jahoda, D., Nyč, O. et al. Bone grafts as vancomycin carriers in local therapy of resistant infections. Folia Microbiol 57, 459–462 (2012). https://doi.org/10.1007/s12223-011-0093-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-011-0093-2